Michael HAURAND

Heteroaryl substituted heterocyclyl sulfones

Fluoromethyl-substituted pyrrole carboxamides iv

Fluoromethyl-substituted pyrrole carboxamides as CaV2.2 calcium channel blockers

FLUOROMETHYL-SUBSTITUTED PYRROLE CARBOXAMIDES III

Aryl substituted heterocyclyl sulfones

Heteroaryl substituted heterocyclyl sulfones

Fluoromethyl-substituted pyrrole carboxamides

Substituted benzo-condensed cycloheptanone derivatives and their use for producing drugs

SUBSTITUTED BIS(HETERO)AROMATIC N--ETHYLPROPIOLAMIDES AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS

Substituted 5,6,7,8-Tetrahydro-pyrido[4,3-d]pyrimidine-2-yl Compounds and 5,6,7,8-Tetrahydro-quinazoline-2-yl Compounds

Substituted thiazoles and their use for producing drugs

SUBSTITUTED PROPIOLIC ACID AMIDES AND THEIR USE FOR PRODUCING DRUGS

Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof

Substituted imidazo[2,1-b]thiazole compounds and uses thereof

Substituted N-Benzo[D]Isoxazol-3-Yl-Amine Compounds as Inhibitors of Mglur5, Serotonin (5-Ht) and Noradrenaline Receptors, and Uses Thereof

Compounds involving mGluR5 receptor regulation and methods of making the compounds

Substituted propiolic acid amides and their use for producing drugs

Sulfonylguanidine compounds and pharmaceutical uses thereof

Substituted 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-2-yl compounds and 5,6,7,8-tetrahydroquinazoline-2-yl compounds

Substituted bicyclic imidazo-3-ylamine compounds

Substituted 1-propiolylpiperazine compounds, their preparation and use

Substituted 1-aminobutan-3-ol compounds

Substituted cyclopentene compounds

Pharmaceutical formulations comprising N,N′-disubstituted piperazine compounds

β-thioamino acids